KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma.

J Thorac Oncol

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

Published: March 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.014DOI Listing

Publication Analysis

Top Keywords

kif5b-met gene
4
gene rearrangement
4
rearrangement robust
4
robust antitumor
4
antitumor activity
4
activity response
4
response crizotinib
4
crizotinib lung
4
lung adenocarcinoma
4
kif5b-met
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!